Just one week into 2019, the new year got off to the proverbial roaring start for biopharma mergers and acquisitions (M&A) with the announcement of two multi-billion-dollar deals valued at a total $82 billion—one of them among the top 10 of all time.
{iframe}https://www.genengnews.com/a-lists/top-10-ma-deals-of-january-june-2019/?utm_medium=newsletter&utm_source=GEN%20Daily%20News%20Highlights&utm_content=01&utm_campaign=GEN%20Daily%20News%20Highlights_20190701&oly_enc_id=1673D8247356B7U{/iframe}